Abstract
40-60% of infants with symptomatic cCMV and 10-15% with asymptomatic infection develop long term sequelae including SNHL, cerebral palsy, neurodevelopmental delay and retinitis. In a third of children with CMV-associated SNHL, the deficits appear later during childhood (delayed-onset SNHL)1,3 The presentation of symptomatic cCMV at birth is highly variable4 and newborn clinical findings predictive of congenital and late-onset SNHL or other sequelae have not been defined
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
